ADVANCED MALIGNANT SOLID TUMORS
Clinical trials for ADVANCED MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to shrink tough tumors
Disease control Recruiting nowThis study tests two experimental drugs, JS212 and JS213, alone or together, in people with advanced solid tumors like kidney, prostate, bladder cancer, or melanoma. The goal is to see if they can shrink tumors and control the disease. About 480 adults will take part to check saf…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New cancer drug JSKN022 enters human testing for advanced tumors
Disease control Recruiting nowThis early-stage trial tests whether JSKN022 is safe for people with advanced solid tumors that have not responded to standard treatments. About 225 adults will receive the drug to check for side effects and see if it can shrink tumors. The main goal is to find a safe dose and un…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new pill (FC084CSA) combined with an immunotherapy (tislelizumab) in people with advanced solid tumors that haven't responded to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors or slow their growth. About 33…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New pill hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests an experimental pill, CSCJC3456, in about 102 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. Participants take the pill …
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:37 UTC